Cargando…
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939853/ https://www.ncbi.nlm.nih.gov/pubmed/36804376 http://dx.doi.org/10.1038/s41408-023-00801-1 |
| _version_ | 1784890953706766336 |
|---|---|
| author | Maples, Kathryn T. Hall, Kevin H. Joseph, Nisha S. Hofmeister, Craig C. Gupta, Vikas Dhodapkar, Madhav V. Kaufman, Jonathan L. Nooka, Ajay K. Lonial, Sagar |
| author_facet | Maples, Kathryn T. Hall, Kevin H. Joseph, Nisha S. Hofmeister, Craig C. Gupta, Vikas Dhodapkar, Madhav V. Kaufman, Jonathan L. Nooka, Ajay K. Lonial, Sagar |
| author_sort | Maples, Kathryn T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9939853 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99398532023-02-21 Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience Maples, Kathryn T. Hall, Kevin H. Joseph, Nisha S. Hofmeister, Craig C. Gupta, Vikas Dhodapkar, Madhav V. Kaufman, Jonathan L. Nooka, Ajay K. Lonial, Sagar Blood Cancer J Correspondence Nature Publishing Group UK 2023-02-20 /pmc/articles/PMC9939853/ /pubmed/36804376 http://dx.doi.org/10.1038/s41408-023-00801-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Maples, Kathryn T. Hall, Kevin H. Joseph, Nisha S. Hofmeister, Craig C. Gupta, Vikas Dhodapkar, Madhav V. Kaufman, Jonathan L. Nooka, Ajay K. Lonial, Sagar Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| title | Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| title_full | Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| title_fullStr | Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| title_full_unstemmed | Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| title_short | Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| title_sort | eliminating the monitoring period with subcutaneous daratumumab: a single-center experience |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939853/ https://www.ncbi.nlm.nih.gov/pubmed/36804376 http://dx.doi.org/10.1038/s41408-023-00801-1 |
| work_keys_str_mv | AT mapleskathrynt eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT hallkevinh eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT josephnishas eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT hofmeistercraigc eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT guptavikas eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT dhodapkarmadhavv eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT kaufmanjonathanl eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT nookaajayk eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience AT lonialsagar eliminatingthemonitoringperiodwithsubcutaneousdaratumumabasinglecenterexperience |